ARTICLE | Emerging Company Profile
CellPoint: bringing autologous CAR Ts to point of care
Emerging Company Profile: CellPoint aims to broaden access to CAR Ts with point-of-care manufacturing platform
June 23, 2021 12:32 PM UTC
CellPoint is looking to broaden the accessibility and affordability of CAR T therapies with a point-of-care manufacturing platform that enables a one-week turnaround between apheresis and treatment delivery.
The Leiden-based newco launched in 2019 with an undisclosed seed funding from +ND Capital to develop a pipeline of CAR T therapies using the Cocoon platform, which produces cell therapies for individual patients in closed, automated pods containing single-use customizable cassettes...